Insulin pump therapy in children with type 1 diabetes: analysis of data from the SWEET registry
Language English Country United States Media print-electronic
Document type Comparative Study, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't
PubMed
27417128
DOI
10.1111/pedi.12416
Knihovny.cz E-resources
- Keywords
- CSII, MDI, childhood diabetes, continuous subcutaneous insulin infusion, multiple daily injections,
- MeSH
- Diabetes Mellitus, Type 1 blood drug therapy MeSH
- Child MeSH
- Injections statistics & numerical data MeSH
- Insulin Infusion Systems statistics & numerical data MeSH
- Infant MeSH
- Blood Glucose * MeSH
- Humans MeSH
- Adolescent MeSH
- Child, Preschool MeSH
- Registries * MeSH
- Check Tag
- Child MeSH
- Infant MeSH
- Humans MeSH
- Adolescent MeSH
- Male MeSH
- Child, Preschool MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Multicenter Study MeSH
- Research Support, Non-U.S. Gov't MeSH
- Comparative Study MeSH
- Names of Substances
- Blood Glucose * MeSH
BACKGROUND: Intensified insulin delivery using multiple daily injections (MDI) or continuous subcutaneous insulin infusion (CSII) is recommended in children with type 1 diabetes (T1D) to achieve good metabolic control. OBJECTIVE: To examine the frequency of pump usage in T1D children treated in SWEET (Better control in Paediatric and Adolescent diabeteS: Working to crEate CEnTers of Reference) centers and to compare metabolic control between patients treated with CSII vs MDI. METHODS: This study included 16 570 T1D children participating in the SWEET prospective, multicenter, standardized diabetes patient registry. Datasets were aggregated over the most recent year of treatment for each patient. Data were collected until March 2016. To assess the organization of pump therapy a survey was carried out. RESULTS: Overall, 44.4% of T1D children were treated with CSII. The proportion of patients with pump usage varied between centers and decreased with increasing age compared with children treated with MDI. In a logistic regression analysis adjusting for age, gender and diabetes duration, the use of pump was associated with both: center size [odd ratio 1.51 (1.47-1.55), P < .0001) and the diabetes-related expenditure per capita [odd ratio 1.55 (1.49-1.61), P < .0001]. Linear regression analysis, adjusted for age, gender, and diabetes duration showed that both HbA1c and daily insulin dose (U/kg/d) remained decreased in children treated with CSII compared to MDI (P < .0001). CONCLUSIONS: Insulin pump therapy is offered by most Sweet centers. The differences between centers affect the frequency of use of modern technology. Despite the heterogeneity of centers, T1D children achieve relatively good metabolic control, especially those treated with insulin pumps and those of younger age.
1st Department of Pediatrics Semmelweis University Budapest Hungary
Barbara Davis Center for Childhood Diabetes University of Colorado Denver Aurora Colorado USA
Child and Young Department APDP Diabetes Lisbon Portugal
Children's University Hospital Children's Endocrinology Centre Riga Stradins University Riga Latvia
DCCP Clinique pédiatrique de Luxembourg Luxembourg Luxembourg
Department of Development and Regeneration KU Leuven Belgium
Department of Paediatrics Medical University of Warsaw Warsaw Poland
Department of Pediatric Endocrinology UZBrussels Brussels Belgium
Department of Pediatrics and Adolescent Medicine of Medical University of Vienna Vienna Austria
Department of Pediatrics University Hospitals Leuven Leuven Belgium
Division of Endocrinology and Diabetes Hospital Sant Joan de Déu Barcelona Spain
Faculty of Medicine Pediatric Endocrinology and Diabetes Ege University İzmir Turkey
German Center for Diabetes Research Munich Neuherberg Germany
Institute for Clinical Sciences Sahlgrenska Achademy University of Gothenburg Gothenburg Sweden
Institute of Epidemiology and Medical Biometry ZIBMT University of Ulm Ulm Germany
Pediatric Department Copenhagen University Hospital Herlev Denmark
Pediatric Endocrinology Hospital Nossa Senhora Das Graças Brazil
Sackler Faculty of Medicine Tel Aviv University Tel Aviv Israel
The Queen Silvia Childrens Hospital Sahlgrenska University Hospital Gothenburg Sweden
Unit of Pediatric Endocrinology and Diabetes Hospital Dona Estefânia Lisbon Portugal
References provided by Crossref.org